Truist Securities Downgrades OrthoPediatrics to Hold, Lowers Price Target to $31

Benzinga · 01/25 11:43
Truist Securities analyst Kaila Krum downgrades OrthoPediatrics (NASDAQ:KIDS) from Buy to Hold and lowers the price target from $39 to $31.